Orbimed Advisors LLC Inmune Bio, Inc. Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
A detailed history of Orbimed Advisors LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 50,000 shares of INMB stock, worth $106,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$106,500% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding INMB
# of Institutions
99Shares Held
6.31MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.73 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.27 Million45.87% of portfolio
-
Ubs Group Ag449KShares$956,8400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$830,5530.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $38.2M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...